Hot Features
Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients w... Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is based in Toronto, Canada. Psyence Biomedical Ltd. is a subsidiary of Psyence Group Inc. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.291 | 10.7777777778 | 2.7 | 3.275 | 2.621 | 44269 | 2.95977967 | CS |
| 4 | -0.929 | -23.6989795918 | 3.92 | 3.9996 | 2.621 | 55617 | 3.27383005 | CS |
| 12 | 0.491 | 19.64 | 2.5 | 16.9593 | 2.4101 | 2768328 | 7.9779517 | CS |
| 26 | 2.2169 | 286.384188089 | 0.7741 | 16.9593 | 0.6147 | 1455628 | 7.32340745 | CS |
| 52 | -2.369 | -44.197761194 | 5.36 | 16.9593 | 0.6147 | 1581853 | 5.23768798 | CS |
| 156 | 0.781 | 35.3393665158 | 2.21 | 16.9593 | 0.0401 | 2367258 | 2.12585981 | CS |
| 260 | 0.781 | 35.3393665158 | 2.21 | 16.9593 | 0.0401 | 2367258 | 2.12585981 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.